Quantifying Bone Disease in Pediatric Rheumatic Patients and It's ProblemsJoachim Peitz*, Oliver Fricke and Eckhard Schoenau
Department of Pediatric Rheumatology and Pediatric Endocrinology, Children’s Hospital, University of Cologne, Germany
- *Corresponding Author:
- Dr. Joachim Peitz
Department of Pediatric Rheumatology and Pediatric Endocrinology Children’s Hospital, University of Cologne, Germany
E-mail: [email protected]
Received date: February 01, 2012; Accepted date: March 04, 2012; Published date: March 08, 2012
Citation: Peitz J, Fricke O, Schoenau E (2012) Quantifying Bone Disease in Pediatric Rheumatic Patients and It’s Problems. Rheumatol Curr Res S2:006. doi:10.4172/2161-1149.S2-006
Copyright: © 2012 Peitz J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
It is well known, that, due to different reasons, children with rheumatic diseases as well as children with other chronic inflammatory diseases suffer from bone disease like osteopenia or osteoporosis. To measure bone mineral density (BMD) or bone mineral content (BMC), Dual X-Ray Absorptiometry (DXA) is used as golden standard. In this review we will show several problems appearing in measuring bone density in children due to multiple reasons, discuss the necessity to have a closer look on bone and muscle as well as on length and bone age on the examined child and end with the few recommendations there are concerning bone disease in pediatric rheumatology patients.